DAVITA INC Reports Third Quarter FY2023 Earnings Results

🌥️Earnings Overview

For the third quarter of FY2023, Davita Inc ($NYSE:DVA) reported total revenue of USD 3121.3 million, showing a 5.9% year-on-year increase. Its net income also rose by 134.1%, resulting in a figure of USD 246.6 million. This quarter ended on September 30 2023.

Market Price

On Tuesday, DAVITA INC reported their third quarter FY2023 earnings results, and the stock opened at $78.2 and closed at $80.1, up by 1.4% from the previous closing price of 79.0. The increase in stock prices was mainly due to an increase in the company’s revenue, which was driven by strong performance in the dialysis clinic and home dialysis segments. Furthermore, the company’s overall operating expenses were lower than the industry average, providing further support for the rise in stock prices. Overall, investors were satisfied with the report and it is expected that the stock will continue to rise in the coming weeks. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Davita Inc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Davita Inc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Davita Inc. More…

Key Ratios Snapshot

Some of the financial key ratios for Davita Inc are shown below. More…

Analysis

At GoodWhale, we analyzed DAVITA INC‘s wellbeing and found it to have a high health score of 8/10. Our Star Chart showed that DAVITA INC is capable of sustaining future operations in times of crisis, based on its cashflows and debt. We also found that the company is strong in profitability, though weak in asset, dividend, and growth. We classified DAVITA INC as a ‘sloth’, meaning that it has achieved revenue or earnings growth slower than the overall economy. This type of company may be of particular interest to investors that look for long-term investments with stable returns. More…

Peers

In the dialysis industry, DaVita Inc. competes with Acadia Healthcare Co Inc, Fresenius Medical Care AG & Co. KGaA, Medical Facilities Corp, and other companies. The company has a network of 2,664 outpatient dialysis centers in the United States that serve approximately 198,000 patients with end-stage renal disease.

– Acadia Healthcare Co Inc ($NASDAQ:ACHC)

Acadia Healthcare Company, Inc. is a provider of behavioral healthcare services. It operates a network of behavioral healthcare facilities in the United States, Puerto Rico, and the United Kingdom. The company offers inpatient psychiatric and substance abuse services, residential treatment, outpatient behavioral health services, and specialty behavioral healthcare services.

– Fresenius Medical Care AG & Co. KGaA ($LTS:0H9X)

Fresenius Medical Care AG & Co. KGaA, a renal care company, provides products and services for patients with renal diseases worldwide. The company’s products and services include dialysis machines, dialyzers, and related disposable products, as well as renal pharmaceuticals. It also offers clinical laboratory testing services. The company was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

– Medical Facilities Corp ($TSX:DR)

Medical Facilities Corporation is a leading operator of specialty surgical hospitals and ancillary services in the United States. The company owns and operates seven specialty surgical hospitals, one surgical hospital, and three surgical facilities located in Arkansas, Illinois, Louisiana, Mississippi, Oklahoma, and Texas. Medical Facilities Corporation’s hospitals offer a broad range of services, including general surgery, cardiovascular surgery, orthopedic surgery, pain management, gastroenterology, urology, and otolaryngology. The company’s hospitals are accredited by the Joint Commission on Accreditation of Healthcare Organizations and are licensed by the respective state Departments of Health.

Summary

The investment analysis for DAVITA INC in the third quarter of FY2023 is looking good. The company reported a total revenue of USD 3121.3 million, representing a 5.9% year-on-year increase. Net income for the same period was USD 246.6 million, representing an impressive 134.1% year-on-year growth.

This is a positive sign for investors as it indicates that the company’s financial performance is trending upwards. It may be a good time to consider investing in DAVITA INC.